• Achieve Life Sciences initiates cytisine clinical development programme biospectrumasia
    August 18, 2017
    Achieve Life Sciences initiates cytisine clinical development programme Cytisine is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe for more than 15 years.
  • Achieve Announces FDA Acceptance of IND Application for Cytisine americanpharmaceuticalreview
    August 14, 2017
    Achieve Life Sciences announced the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for cytisine, an established smoking cessation treatment that has been approved and marketed in Central and Eastern Eur
PharmaSources Customer Service